Drug Type Small molecule drug |
Synonyms CE 245677 |
Target |
Action inhibitors, antagonists |
Mechanism NTRK inhibitors(Neurotrophic tyrosine kinase receptor inhibitors), Tie-2 antagonists(TEK receptor tyrosine kinase antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H22Cl2N6O3 |
InChIKeyVFCRSIORGUNNGT-UHFFFAOYSA-N |
CAS Registry717899-97-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Phase 1 | - | - | |
| Inflammatory pain | Preclinical | United Kingdom | - |





